Apricot Bio Science Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 1.50 M
- Company Age 2 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.00 M
About Apricot Bio Science
Apricot Bio Science Private Limited (ABSPL) is a Private Limited Indian Non-Government Company incorporated in India on 23 June 2022 (Two years and seven months 18 days old ). Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.50 M.
The company currently has active open charges totaling ₹2.00 M.
Anuj Chouksey and Surendra Raghuwanshi serve as directors at the Company.
Company Details
-
Location
Thane, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51397MH2022PTC385282
-
Company No.
385282
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
23 Jun 2022
-
Date of AGM
31 Dec 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Apricot Bio Science?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anuj Chouksey
|
Director | 23-Jun-2022 | Current |
|
Surendra Raghuwanshi
|
Director | 23-Jun-2022 | Current |
Financial Performance of Apricot Bio Science.
Apricot Bio Science Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Apricot Bio Science?
Unlock access to Apricot Bio Science's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Capstone Pharma Private LimitedAnuj Chouksey is a mutual person
-
Bioapricot Life Science Rivate Limited
Surendra Raghuwanshi is a mutual person
Charges (Loans)
₹2.00 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.20 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Mar 2024 | State Bank Of India | ₹2.00 M | Open |
How Many Employees Work at Apricot Bio Science?
Apricot Bio Science has a workforce of 0 employees as of Apr 11, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Apricot Bio Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Apricot Bio Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.